Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Neurology
General Psychiatry
Questions discussed in this category
Do you warn patients about suicidal ideation when starting anti-seizure medications?
1 Answer available
What is the best approach to treatment for cenestopathies (sensation of electric current in patient's brain) accompanied by anxiety and inability to sleep?
2 Answers available
Would you use bupropion for mood disorder or substance use in an adult patient with previous childhood seizures that resolved?
1 Answer available
Are the laws regarding prescribing C-2 medications different for mail order pharmacies?
How is it that I'm able to prescribe medications to patients (in my state) via legitimate mail order pharmacies that are located in a different state?...
2 Answers available
How do you navigate C-2 refills in patients who are stable in their treatment and do not otherwise need to be clinically seen monthly?
Would you consider charging a small fee for managing C-2 prescriptions between appointments instead of requiring the patient to come monthly?
4 Answers available
When do you use seizure prophylaxis in patients on clozapine?
5 Answers available
Do you avoid triptans in patients on SSRI's due to the potential risk of serotonin syndrome?
7 Answers available
Would you avoid the use of keppra in patients with TBI due to concerns for worsening agitation?
2 Answers available
How do you evaluate patients with suspected pseudo-dementia?
1 Answer available
How do you approach the management of patients on lamotrigine who develop a minor rash?
Should one restart lamotrigine or look for an alternative? If no other alternative available, is slow titration vs regular titration preferred?
4 Answers available
18655
21431
20775
21834
21672
21313
17868
16768
16413
11290
Papers discussed in this category
Headache, 2010-06
The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American Headache Society position paper.
Headache, 2012 Jan 30
Concomitant use of triptan, and SSRI or SNRI after the US Food and Drug Administration alert on serotonin syndrome.
Neurology, 2019 Dec 02
Triptan and ergotamine overdoses in the United States: Analysis of the National Poison Data System.
Headache, 2023 Jan 27
Utilization patterns, cardiovascular risk, and concomitant serotoninergic medications among triptan users between 2008 and 2018: A gender analysis in one Italian region, Tuscany.
Cureus, 2023 May 11
Serotonin Syndrome: The Role of Pharmacology in Understanding Its Occurrence.
JAMA neurology, 2018-05-01
Association of Coprescription of Triptan Antimigraine Drugs and Selective Serotonin Reuptake Inhibitor or Selective Norepinephrine Reuptake Inhibitor Antidepressants With Serotonin Syndrome.
Neurology, 1991 Mar
Clozapine-related seizures.
Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 2013 Aug 31
Use of anticonvulsants as prophylaxis for seizures in patients on clozapine.
The primary care companion for CNS disorders, 2018 Dec 20
Brain Zaps: An Underappreciated Symptom of Antidepressant Discontinuation.
Related Topics in Neurology
Breast Cancer
Head and Neck Cancers
Hematologic Malignancies
Radiation Oncology
Gynecologic Cancers
Palliation
Neuro-Oncology
Gastrointestinal Cancers
Non-malignant Disease
Pediatric Hematology/Oncology